1 Updates

Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+

Sep 29 2013, 11:48am CDT | by PR.com

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD).

DeLand, FL, September 29, 2013 --(PR.com)-- To see if you qualify for this COPD Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us...

Filed under: news

Full Story below YouTube Videos

 
 

 

29 weeks ago

Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+

Sep 29 2013, 11:48am CDT | by PR.com

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD).

DeLand, FL, September 29, 2013 --(PR.com)-- To see if you qualify for this COPD Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance is required, and you may receive compensation for time and travel.

Study Design
This study is designed to evaluate the effect of an experimental inhalation therapy administered once daily via a Novel Dry Powder Inhaler on arterial stiffness compared with placebo and vilanterol over a 24 - week treatment period in subjects with COPD. Vilanterol is included to help explain relative treatment effect of this experimental inhalation therapy in the new combination, however the comparison is not powered. Arterial stiffness will be measured as aPWV. This is a randomised, placebo-controlled, multicenter study. Subjects who meet the eligibility criteria at Screening and meeting the randomisation criteria at the end of a 2-week Run-In period will enter a 24-week treatment period. There will be an approximately 7-day Follow-Up period after the treatment period.

Background & Rationale
Arterial stiffness is increasingly recognized as a surrogate marker for cardiovascular disease (CVD). In particular, arterial stiffness has been shown to be an independent predictor of future fatal and non-fatal CV events and all-cause mortality in hypertensive patients, apparently healthy elderly subjects and a general population. Arterial stiffness can be measured with non-invasive, reproducible and inexpensive techniques, which make it feasible to implement into clinical practice and large-scale clinical studies.

Primary Objectives
The primary objective of the study is to evaluate the effect of an experimental inhalation therapy administered once daily (QD) compared with placebo on aPWV in subjects with COPD and aPWV ≥ 11.0 m/s at baseline.

Inclusion Criteria
1. Type of subject: outpatient
2. Informed consent: Subjects must give their signed and dated written informed consent to participate.
3. Gender: Male or female subjects

A female is eligible to enter and participate in the study if she is of:
-Non-child bearing potential (i.e., physiologically incapable of becoming pregnant, including any female who is post-menopausal or surgically sterile).
-Child bearing potential, has a negative pregnancy test at screening, and agrees to one of the following acceptable contraceptive methods used consistently and correctly:
-- Complete abstinence from intercourse from screening until the Follow-Up Phone Contact; or
-- Male partner is sterile (vasectomy with documentation of azoospermia) prior to female subject entry into the study, and this male partner is the sole partner for that subject; or
-- Implants of levonorgestrel inserted for at least 1 month prior to the study medication administration but not beyond the third successive year following insertion; or
-- Injectable progestogen administered for at least 1 month prior to study medication administration and administered until the Follow-Up Phone Contact; or
-- Oral contraceptive (combined or progestogen only) administered for at least one monthly cycle prior to study medication administration; or
-- Double barrier method: condom and occlusive cap (diaphragm or cervical/vault caps) with spermicidal agent (foam/gel/film/cream/suppository); or
-- An intrauterine device (IUD), inserted by a qualified physician, with published data showing that the highest expected failure rate is less than 1 per year; or
-- Estrogenic vaginal ring; or
-- Percutaneous contraceptive patches

4. Age: ≥40 years of age at Screening (Visit 1)
5. COPD diagnosis: Subjects with a clinical history of COPD
6. Tobacco use: Subjects with a current or prior history of ≥10 pack-years of cigarette smoking at Screening
7. Severity of Disease:

Subjects with a measured post-albuterol/salbutamol FEV1 ≤70% of predicted normal values calculated using NHANES III reference equations at Screening (Visit 1)
Subject with a measured post-albuterol/salbutamol FEV1/FVC ratio of ≤0.70 at Screening (Visit 1)
Post-bronchodilator spirometry will be performed approximately 10-15 minutes after
the subject has self-administered 4 inhalations (i.e., total 400mcg) of albuterol/salbutamol via an MDI with a valved-holding chamber.
8. Baseline aPWV: subjects with a measured aPWV≥11.0 m/s at Screening (Visit 1)

Contact Information:
Avail Clinical Research
Jennifer Economou
(386) 785-2400 336
Contact via Email
www.availclinical.com

Read the full story here: http://www.pr.com/press-release/518663

Press Release Distributed by PR.com

Source: PR.com

 

Don't miss ...

 

blog comments powered by Disqus

Latest stories

Odyne Systems, LLC Partners with Allison Transmission’s Midwest Distributor, Inland Power, to Deliver on $45.4 Million Contract
Odyne Systems, LLC Partners with Allison Transmission’s Midwest Distributor, Inland Power, to Deliver on $45.4 Million Contract
Department of Energy Program Administered Through the Electric Power Research Institute to Apply Over 120 Odyne Plug-In Hybrid Systems to Trucks Throughout North America
 
 
Cleared Of Fraud Against SMEs, RBS Eases Rules For Distressed Businesses
Last week, The Royal Bank of Scotland Group was cleared by law firm Clifford Chance over allegations that the U.K.-based banking group deliberately put failing small and medium enterprise customers out of business to...
 
 
Cost Savings Are Allowing Colgate To Invest Back In Building Brands And Products
In the past several quarters, balancing the business mix between developed and emerging markets has helped Colgate-Palmolive to achieve above market growth and experience only a moderate impact on net sales from...
 
 
Shift In Agricultural Sales Timing, Lower Chemical Prices Weigh On DuPont's Earnings Growth
DuPont reported modest earnings growth for the first quarter due to lower agricultural sales volume and continuing pricing pressures in the chemicals segment. The company’s adjusted diluted earnings per share of $1.58...
 
 
 

Latest from the Network

Apple's Sales Figures Prove A Sad Fact: There's Still No PC As Desirable As A Mac
Mac sales make up just a tenth of Apple's revenue, but they’ve received a significant amount of attention following the company’s quarterly report yesterday, both from analysts and from the CEO Tim Cook himself. Cook’s...
Read more on Apple Balla
 
Apple's Analysts Almost Universally Positive On The March Quarter Results
Apple’s shares are up over $40 today driven by its very solid March quarter results and better than expected guidance for the June quarter. I have summarized over a dozen sell-side notes below and many analysts have...
Read more on Apple Balla
 
Odyne Systems, LLC Partners with Allison Transmission’s Midwest Distributor, Inland Power, to Deliver on $45.4 Million Contract
Waukesha, WI, April 24, 2014 --(PR.com)-- Odyne Systems of Waukesha and Inland Power Group of Butler, Wisconsin have teamed up to deliver on a $45.4 million contract from the Department of Energy, administered through...
Read more on Politics Balla
 
Odyne Systems, LLC Partners with Allison Transmission’s Midwest Distributor, Inland Power, to Deliver on $45.4 Million Contract
Waukesha, WI, April 24, 2014 --(PR.com)-- Odyne Systems of Waukesha and Inland Power Group of Butler, Wisconsin have teamed up to deliver on a $45.4 million contract from the Department of Energy, administered through...
Read more on Business Balla
 
Cleared Of Fraud Against SMEs, RBS Eases Rules For Distressed Businesses
Last week, The Royal Bank of Scotland Group was cleared by law firm Clifford Chance over allegations that the U.K.-based banking group deliberately put failing small and medium enterprise customers out of business to...
Read more on Business Balla
 
Cost Savings Are Allowing Colgate To Invest Back In Building Brands And Products
In the past several quarters, balancing the business mix between developed and emerging markets has helped Colgate-Palmolive to achieve above market growth and experience only a moderate impact on net sales from...
Read more on Business Balla
 
Shift In Agricultural Sales Timing, Lower Chemical Prices Weigh On DuPont's Earnings Growth
DuPont reported modest earnings growth for the first quarter due to lower agricultural sales volume and continuing pricing pressures in the chemicals segment. The company’s adjusted diluted earnings per share of $1.58...
Read more on Business Balla
 
Google's Glass Explorer Program Was A Social Experiment That Backfired
Google Glass was launched without any clear explanation of what it was supposed to be used for. When promotional videos started to show people going about their daily routine, it quickly became clear that what we were...
Read more on Business Balla
 
America's 100 Best Corporate Citizens in 2014
America’s 10 Best Corporate Citizens In 2014 In December Bristol-Myers Squibb joined the Medicines Patent Pool, an international organization in Geneva, Switzerland, that makes drugs available at low cost to people...
Read more on Business Balla
 
Talent Knows No Limits
Last month I had the pleasure of attending Cirque Du Soleil’s Michael Jackson tribute The Immortal World Tour. To say the performance was out of this world would be an understatement. If you’ve ever seen a Cirque show...
Read more on Business Balla
 
 
Auto Balla Sexy Balla Sport Balla TV Balla Politics Balla Movie Balla Apple Balla Business Balla Ad Balla Celebrity Balla